Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNF inhibitors versus intensive conventional DMARD combination therapy in established rheumatoid arthritis
2007-001190-28Phase 4Completed
- Sponsor
- King's College London
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of infliximab, etanercept, adalimumab, methotrexate, 5-aminosalicylic acid + sulphasalazine and 6 more in rheumatoid arthritis (RA) (2 arms), sponsored by King's College London. Primary endpoint: Change in Health Assessment Questionnaire score at 12 months. Started Apr 2007; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-001190-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001190-28.